Expression and characterization of recombinant gallinacin-9 and gallinacin-8 in Escherichia coli

Protein Expression and Purification

Volumn 58, Issue 2, 2008, Pages 284-291

  Ma, De ying ^a   Liu, Sheng wang ^b   Han, Zong xi ^b   Li, Yi jin ^a   Shan, An shan ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b Harbin Veterinary Research Institute   (China)

Author keywords

Antibacterial activity; Antimicrobial peptides; Chick; Fusion protein; Gallinacins

Indexed keywords

BETA DEFENSIN; GALLINACIN 8 PROTEIN, CHICKEN; GALLINACIN 9 PROTEIN, CHICKEN; GALLINACIN-8 PROTEIN, CHICKEN; GALLINACIN-9 PROTEIN, CHICKEN; HYBRID PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMISTRY; CHICKEN; DRUG EFFECT; ESCHERICHIA COLI; METABOLISM; MICROBIOLOGICAL EXAMINATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN FOLDING; STREPTOCOCCUS SUIS; TISSUE DISTRIBUTION;

ANIMALS; BETA-DEFENSINS; CHICKENS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; PROTEIN FOLDING; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; STREPTOCOCCUS SUIS; TISSUE DISTRIBUTION;

AVES; ESCHERICHIA COLI; GALLUS GALLUS; STREPTOCOCCUS;

EID: 39549084719     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.11.017     Document Type: Article

References (44)

1. Donoghue D.L. Antibiotic residues in poultry tissues and eggs: human health concerns?. Poult Sci. 82 (2003) 618-621
2. Peschel A. How do bacteria resist human antimicrobial peptides?. Trends Microbiol. 10 (2002) 179-186
3. Roe M.T., and Pillai S.D. Monitoring and identifying antibiotic resistance mechanisms in bacteria. Poult Sci. 82 (2003) 622-626
4. Kagan B.L., Selsted M.E., Ganz T., and Lehrer R.I. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc. Natl. Acad. Sci. USA 87 (1990) 210-214
5. Sugiarto H., and Yu P.L. Avian antimicrobial peptides: the defense role of β-defensins. Biochem. Biophys. Res. Commun. 323 (2004) 721-727
6. Satchell D.P., Sheynis T., Shirafuji Y., Kolusheva S., Ouellette A.J., and Jelinek R. Interactions of mouse Paneth cell alpha-defensins and alpha-defensin precursors with membranes. Prosegment inhibition of peptide association with biomimetic membranes. J. Biol. Chem. 278 (2003) 13838-13846
7. Bensch K.W., Raida M., Magert H.J., Schulz-Knappe P., and Forssmann W.G. hBD-1: a novel β-defensin from human plasma. FEBS Lett. 368 (1995) 331-335
8. Higgs R., Lynn D.J., Gaines S., Mcmahon J., Tierney J., James T., Lloyd A.T., Mulcahy G., and O'Farrelly C. The synthetic form of a novel chicken β-defensin identified in silico is predominantly active against intestinal pathogens. Immunogenetics 57 (2005) 90-98
9. Harwig S.S.L., Swiderek K.M., Kokryakov V.N., Tan L., Lee T.D., Panyutich E.A., Aleshina G.M., Shamova O.V., and Lehrer R.I. Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes. FEBS Letters. 342 (1994) 281-285
10. Lynn D.J., Higgs R., Gaines S., Tierney J., James T., Lloyd A.T., Fares M.A., Mulcahy G., and O'Farrelly C. Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken. Immunogenetics 56 (2004) 170-177
11. Zhao C.Q., Nguyen T., Liu L., Sacco R.E., Brogden K.A., and Lehrer R.I. Gallinacin-3, an inducible epithelial β-defensin in the chicken. Infect. Immun. 69 (2001) 2684-2691
12. Evans E.W., Beach G.G., Wunderlich J., and Harmon B.G. Isolation of antimicrobial peptides from avian heterophils. J. Leukoc. Biol. 56 (1994) 661-665
13. Evans E.W., Beach F.G., Moore K.M., Jackwood M.W., Glisson J.R., and Harmon B.G. Antimicrobial activity of chicken and turkey heterophil peptides CHP1, CHP2, THP1, and THP3. Vet. Microbiol. 47 (1995) 295-303
14. Zhang G., Wu H., Shi J., Ganz T., Ross C.R., and Blecha F. Molecular cloning and tissue expression of porcine β-defensin-1. FEBS Lett. 424 (1998) 37-40
15. Wei Q., Kim Y.S., Seo J.H., Jang W.S., Lee I.H., and Cha H.J. Facilitation of expression and purification of an antimicrobial peptide by fusion with baculoviral polyhedrin in Escherichia coli. Appl. Environ. Microbiol. 71 (2005) 5038-5043
16. Rao X.C., Li S., Hu J.C., Jin X.L., Hu X.M., Huang J.J., Chen Z.J., Zhu J.M., and Hu F.Q. A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli. Protein Expr. Purif. 36 (2004) 11-18
17. Marzena P., and Lubkowski J. Expression and purification of recombinant human α-defensins in Escherichia coli. Protein Expr. Purif. 49 (2006) 1-8
18. Feng X.J., Wang J.H., Shan A.S., Teng D., Yang Y.L., Yao Y., Yang G.P., Shao Y.C., Liu S., and Zhang F. Fusion expression of bovine lactoferricin in Escherichia coli. Protein Expr. Purif. 47 (2006) 110-117
19. Sambrook J., Fristsch E.F., and Maniatis T. In: Sambrook J. (Ed). Molecular Cloning: A Laboratory Manual. third ed. (1989), Cold Spring Harbor Laboratory Press, New York 96-99
20. Schagger H., and von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166 (1987) 368-379
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
22. Lehrer R.I., Rosenman M., Harwig S.S., Jackson R., and Eisenhauer P. Ultrasensitive assays for endogenous antimicrobial polypeptides. J. Immunol. Methods 137 (1991) 167-173
23. Bulet P., Dimarcq J.L., Hetru C., Lagueux M., Charlet M.M., Hegy G., Van Dorsselaer A., and Hovmann J.A. A novel inducible antibacterial peptide of Drosophila carries an O-glycosylated substitution. J. Biol. Chem. 268 (1993) 14893-14897
24. Harmon B.G. Avian heterophils inflammation and disease resistance. Poult. Sci. 77 (1998) 972-977
25. Chertov O., Michiel D.F., Xu L., Wang J.M., Tani K., Murphy W.J., Longo D.L., Taub D.D., and Oppenheim J.J. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271 (1996) 2935-2940
26. Koczulla R., von Degenfeld G., Kupatt C., Krotz F., Zahler S., Gloe T., Issbrucker K., Unterberger P., Zaiou M.M., Lebherz C., Karl A., Raake P., Professor A., Boekstegers P., Welsch U., Hiemstra P.S., Vogelmeier C., Gallo R.L., Clauss M., and Bals R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111 (2003) 1665-1672
27. Schonwette B.S., Stolzenberg E.D., and Zasloff M.A. Epithelial antibiotics induced at sites of inflammation. Science 267 (1995) 1645-1648
28. Shi J., Zhang G., Wu H., Ross C., Blecha F., and Ganz T. Porcine epithelial β-defensin 1 is expressed in the dorsal tongue at antimicrobial concentrations. Infect. Immun. 67 (1999) 3121-3127
29. Cunliffe R.N., and Mahida Y.R. Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J. Leukoc. Biol. 75 (2004) 49-58
30. O'Neil D.A., Porter E.M., Elewaut D., Anderson G.M., Eckmann L., Ganz T., and Kagnoff M.F. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol. 163 (1999) 6718-6724
31. Bals R., Wang X., Meegalla R.L., Wattler S., Weiner D.J., Nehls M.C., and Wilson J.M. Mouse β-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs. Infect. Immun. 67 (1999) 3542-3547
32. Ghosh D., Porter E., Shen B., Lee S.K., Wilk D., Drazba J., Yadav S.P., Crabb J.W., Ganz T., and Bevins C.L. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat. Immunol. 3 (2002) 583-590
33. Valore E.V., and Ganz T. Posttranslational processing of defensins in immature human myeloid cells. Blood 79 (1992) 538-1544
34. Harwig S.S.L., Park A.S., and Lehrer R.I. Characterization of defensin precursors in mature human neutrophils. Blood 79 (1992) 1532-1537
35. Valore E.V., Martin E., Harwig S.S., and Ganz T. Intramolecular inhibition of human defensin HNP-1 by its propiece. J. Clin. Invest. 97 (1996) 1624-1629
36. Piers K.L., Brown M.H., and Hancock R.E. Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene 134 (1993) 7-13
37. Fairlie W.D., Uboldi A.D., De Souza D.P., Hemmings G.J., Nicola N.A., and Baca M. A fusion protein system for the recombinant production of short disulfide-containing peptides. Protein Expr. Purif. 26 (2002) 171-178
38. Dobeli H., Andres H., Breyer N., Draeger N., Sizmann D., Zuber M.T., Weinert B., and Wipf B. Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: purification, oxidation without concatamer formation, and selective cleavage. Protein Expr. Purif. 12 (1998) 404-414
39. Kohno T., Kusunoki H., Sato K., and Wakamatsu K. A new general method for the biosynthesis of stable isotope-enriched peptides using a decahistidine-tagged ubiquitin fusion system: an application to the production of mastoparan-X uniformly enriched with 15N and 15N/13C. J. Biomol. NMR 12 (1998) 109-121
40. Toye B., Zhong G.M., Peeling R., and Brunham R.C. Immunologic characterization of a cloned fragment containing the species-specified epitope from the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 58 (1990) 3909-3913
41. Fikrig E., Barthold S.W., Kantor F.S., and Flavell R.A. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 250 (1990) 553-556
42. Kaelin W.G.J., Pallas D.C., DeCaprio J.A., Kaye F.J., and Livingston D.M. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 64 (1991) 521-532
43. Chittenden T., Livingston D.M., and Kaelin W.G.J. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65 (1991) 1073-1082
44. Fischer B.E. Renaturation of recombinant proteins produced as inclusion bodies. Biotechnol. Adv. 12 (1994) 89-101